Definium Therapeutics, Inc. (DFTX) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $257.84M | -5.8% |
| 2024 | $273.74M | +174.6% |
| 2023 | $99.70M | -29.9% |
| 2022 | $142.14M | +6.4% |
| 2021 | $133.54M | +66.7% |
| 2020 | $80.09M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $257.84M | -5.8% |
| 2024 | $273.74M | +174.6% |
| 2023 | $99.70M | -29.9% |
| 2022 | $142.14M | +6.4% |
| 2021 | $133.54M | +66.7% |
| 2020 | $80.09M | — |